Compare PL & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PL | GKOS |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.3B |
| IPO Year | N/A | 2015 |
| Metric | PL | GKOS |
|---|---|---|
| Price | $25.98 | $119.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | $15.55 | ★ $132.00 |
| AVG Volume (30 Days) | ★ 14.1M | 847.6K |
| Earning Date | 03-19-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $282,459,000.00 | ★ $469,820,000.00 |
| Revenue This Year | $26.28 | $32.39 |
| Revenue Next Year | $26.97 | $23.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.89 | ★ 30.38 |
| 52 Week Low | $2.79 | $73.16 |
| 52 Week High | $30.90 | $161.78 |
| Indicator | PL | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 54.11 |
| Support Level | $25.13 | $116.73 |
| Resistance Level | $28.70 | $128.84 |
| Average True Range (ATR) | 2.23 | 6.18 |
| MACD | -0.26 | 0.07 |
| Stochastic Oscillator | 45.98 | 70.18 |
Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.